BHVN
Brown Advisory’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-752,048
| Closed | -$114M | – | 1254 |
|
|
2022
Q3 | $114M | Sell |
752,048
-19,124
| -2% | -$2.89M | 0.22% | 97 |
|
|
2022
Q2 | $112M | Sell |
771,172
-112,398
| -13% | -$16.4M | 0.21% | 101 |
|
|
2022
Q1 | $105M | Buy |
883,570
+34,691
| +4% | +$4.11M | 0.16% | 114 |
|
|
2021
Q4 | $117M | Sell |
848,879
-184,323
| -18% | -$25.4M | 0.15% | 110 |
|
|
2021
Q3 | $144M | Sell |
1,033,202
-8,163
| -0.8% | -$1.13M | 0.21% | 95 |
|
|
2021
Q2 | $101M | Buy |
1,041,365
+51,677
| +5% | +$5.02M | 0.15% | 118 |
|
|
2021
Q1 | $67.6M | Buy |
989,688
+101,404
| +11% | +$6.93M | 0.12% | 148 |
|
|
2020
Q4 | $76.1M | Buy |
888,284
+28,891
| +3% | +$2.48M | 0.14% | 126 |
|
|
2020
Q3 | $55.9M | Buy |
859,393
+11,374
| +1% | +$739K | 0.12% | 130 |
|
|
2020
Q2 | $62M | Buy |
848,019
+67,578
| +9% | +$4.94M | 0.14% | 118 |
|
|
2020
Q1 | $26.6M | Buy |
780,441
+72,757
| +10% | +$2.48M | 0.08% | 174 |
|
|
2019
Q4 | $38.5M | Sell |
707,684
-382,308
| -35% | -$20.8M | 0.1% | 169 |
|
|
2019
Q3 | $45.5M | Buy |
1,089,992
+81,946
| +8% | +$3.42M | 0.13% | 146 |
|
|
2019
Q2 | $44.1M | Buy |
1,008,046
+380,764
| +61% | +$16.7M | 0.13% | 157 |
|
|
2019
Q1 | $32.3M | Buy |
627,282
+173,873
| +38% | +$8.95M | 0.09% | 192 |
|
|
2018
Q4 | $16.8M | Buy |
+453,409
| New | +$16.8M | 0.06% | 251 |
|